Study of obicetrapib on antioxidants in healthy adults
Treatments studied
This trial tests whether a new cholesterol-lowering drug, obicetrapib, affects antioxidant levels in the blood and HDL (good cholesterol) particles. It is currently for healthy volunteers only.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can see at 20/60 or better in both eyes (with or without glasses).
- You do not have type 2 diabetes.
- You do not have active liver disease.
- You do not have any significant eye problem affecting the macula (the center of your vision).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a new drug called obicetrapib can help people who have early signs of Alzheimer's disease but no symptoms yet. It aims to see if the drug can slow or prevent the disease from progressing.
This study compares two new medicines—obicetrapib and bempedoic acid—to see which one better lowers cholesterol in people whose cholesterol remains high despite taking standard medications. If your cholesterol isn't controlled well enough with current drugs, this trial may help you access an experimental treatment.
This study tests two new drugs, alone and together, to lower a type of cholesterol called Lp(a) that increases heart disease risk. You may qualify if you have high Lp(a) and your LDL cholesterol is still high despite current treatment.
This study tests a new drug called CG-0416 in healthy volunteers to see how safe it is and how the body handles it. The drug is given as a single dose or repeated doses, and researchers will monitor your health and cholesterol levels.
This trial tests a new drug called RN5681 to see if it is safe and how the body processes it. It is for healthy people with certain cholesterol levels and may help people with high cholesterol or heart risk in the future.
This study tests if taking a carotenoid supplement (MacuHealth) can improve or protect retinal health in healthy adults. You might join if you have normal vision and no major eye or health problems.
Hear when a new Antioxidant Absorption trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.